Vortex Energy【VRTX】銘柄情報

	リアルタイム株価	レベル2
Forex

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.055

買値

0.05

売値

0.055

出来高

55,500

0.05 日の範囲 0.055

0.05 52 週間の範囲 0.85

前日終値

0.05

始値

0.05

時刻

2000

0.055

最終取引時間

平均取引量 (3 か月)

127,349

財務取引量

VWAP

Vertex Pharmaceuticals Announces the Date of its Third Quarter 2006 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., Oct. 9 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will announce its third quarter 2006 financial results on Thursday, October 26, 2006...

Vertex Pharmaceuticals Announces Completion of Common Stock Offering

CAMBRIDGE, Mass., Sept. 20 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) today announced the completion of its public offering of 9,100,000 shares of common...

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences

CAMBRIDGE, Mass., Sept. 18 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will webcast corporate presentations at Merrill Lynch's Global Pharmaceutical, Biotech...

Vertex Pharmaceuticals Announces Pricing of Common Stock Offering

CAMBRIDGE, Mass., Sept. 14 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) today announced the pricing of its public offering of 9,100,000 shares of its common...

Vertex and Merck Initiate Clinical Study in Hematologic Cancers with Aurora Kinase Inhibitor VX-680

Vertex and Merck Initiate Clinical Study in Hematologic Cancers with Aurora Kinase Inhibitor VX-680 WHITEHOUSE STATION, N.J. and CAMBRIDGE, Mass., June 17 /PRNewswire/ -- Merck & Co., Inc...

Vertex Pharmaceuticals Reports Positive Results from First-in-Human Study for VX-950, an Investigational Oral Protease Inhibitor

Vertex Pharmaceuticals Reports Positive Results from First-in-Human Study for VX-950, an Investigational Oral Protease Inhibitor for the Treatment of Hepatitis C -- Encouraging Results Support...

Studies of Sustained Efficacy/Tolerability of LEXIVA After 96 Weeks of Treatment Presented at IAC

Studies of Sustained Efficacy/Tolerability of LEXIVA After 96 Weeks of Treatment Presented at IAC BANGKOK, Thailand, July 13 /PRNewswire-FirstCall/ -- The protease inhibitor (PI) LEXIVA(R...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.005	-8.33333333333	0.06	0.06	0.05	77128	0.05121317	CS
4	-0.02	-26.6666666667	0.075	0.075	0.05	143832	0.05710762	CS
12	-0.085	-60.7142857143	0.14	0.14	0.05	127349	0.08393754	CS
26	-0.17	-75.5555555556	0.225	0.27	0.05	87363	0.11977236	CS
52	-0.365	-86.9047619048	0.42	0.85	0.05	155247	0.37152417	CS
156	-0.045	-45	0.1	2.32	0.05	199072	0.91983776	CS
260	-0.045	-45	0.1	2.32	0.05	199072	0.91983776	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ACRG.A.UAcreage Holdings Inc	US$ 0.01 (100.00%)	1.84k
BEEBee Vectoring Technologies International Inc	$ 0.01 (100.00%)	156.54k
VTALJustera Health Ltd	$ 0.01 (100.00%)	20k
MINAMinas Metals Ltd	$ 0.01 (100.00%)	2.31k
FFF55 North Mining Inc	$ 0.01 (100.00%)	2k
MLKMMayo Lake Minerals Inc	$ 0.02 (-55.56%)	22.38k
CHGXChitogenX Inc	$ 0.005 (-50.00%)	215k
FNQFineqia International Inc	$ 0.005 (-50.00%)	69.39k
EOMEco Oro Minerals Corp	$ 0.005 (-50.00%)	7k
GPKGrand Peak Capital Corp	$ 0.10 (-50.00%)	1.5k
SPMTSpearmint Resources Inc	$ 0.02 (0.00%)	4.98M
QIMCQuebec Innovative Materials Corp	$ 0.135 (-6.90%)	1.79M
AIMLAl ML Innovations Inc	$ 0.105 (-4.55%)	1.78M
CACRKWG Resources Inc	$ 0.015 (0.00%)	1.78M
MILIMilitary Metals Corp	$ 0.39 (23.81%)	1.4M